Biomaterials-Involved Construction of Extracellular Matrices for Tumor Blockade Therapy

Jinfeng Sun1,2, Yang Liu1,3,4, Jingshan Sun1,3

  • 1Key Laboratory of Polymer Ecomaterials Changchun Institute of Applied Chemistry, Chinese Academy of Sciences Changchun P. R. China.

PubMed

Insights

Artificial extracellular matrices (ECMs) offer novel tumor therapy strategies. Biomaterials can induce biomineralization, fibrogenesis, or gelation to overcome limitations of current ECM-targeting cancer treatments.

Area of Science:

  • Biomedical Engineering
  • Oncology
  • Materials Science

Background:

  • Extracellular matrices (ECMs) are critical in tumor progression, proliferation, and metastasis.
  • Current therapies targeting tumor ECMs have limitations, including unintended side effects and treatment resistance.

Purpose of the Study:

  • To explore artificial ECM fabrication techniques for tumor therapy.
  • To discuss the benefits and challenges of biomineralization, fibrogenesis, and gelation strategies.
  • To highlight future research directions for advanced artificial ECMs in cancer treatment.

Main Methods:

  • Review of current literature on ECM-targeting cancer therapies.
  • Analysis of biomaterial-based artificial ECM fabrication methods.
  • Discussion of therapeutic strategies including biomineralization, fibrogenesis, and gelation.

Main Results:

  • Biomaterials can be engineered to create artificial ECMs.
  • Artificial ECMs can be fabricated using biomineralization, fibrogenesis, or gelation.
  • These approaches offer potential to overcome limitations of current ECM-targeting therapies.

Conclusions:

  • Artificial ECMs present a promising avenue for innovative tumor therapy.
  • Further research into biomaterial design and fabrication is crucial for clinical translation.
  • Optimized artificial ECMs could enhance drug delivery and immune cell infiltration, improving cancer treatment outcomes.